The Estrogen-regulated Transcription Factor PITX1 Coordinates Gene-specific Regulation by Estrogen Receptor-alpha in Breast Cancer Cells

Overview

Journal Mol Endocrinol

Specialties Endocrinology
Molecular Biology

Date 2011 Aug 27

PMID 21868451

Citations 16

Authors

Joshua D Stender

Fabio Stossi

Cory C Funk

Tze Howe Charn

Daniel H Barnett

Benita S Katzenellenbogen

Affiliations

Soon will be listed here.

Abstract

The estrogen receptor α (ERα) is a master regulator of gene expression and works along with cooperating transcription factors in mediating the actions of the hormone estradiol (E2) in ER-positive tissues and breast tumors. Here, we report that expression of paired-like homeodomain transcription factor (PITX1), a tumor suppressor and member of the homeobox family of transcription factors, is robustly up-regulated by E2 in several ERα-positive breast cancer cell lines via ERα-dependent interaction between the proximal promoter and an enhancer region 5' upstream of the PITX1 gene. Overexpression of PITX1 selectively inhibited the transcriptional activity of ERα and ERβ, while enhancing the activities of the glucocorticoid receptor and progesterone receptor. Reduction of PITX1 by small interfering RNA enhanced ERα-dependent transcriptional regulation of a subset of ERα target genes. The consensus PITX1 binding motif was found to be present in 28% of genome-wide ERα binding sites and was in close proximity to estrogen response elements in a subset of ERα binding sites, and E2 treatment enhanced PITX1 as well as ERα recruitment to these binding sites. These studies identify PITX1 as a new ERα transcriptional target that acts as a repressor to coordinate and fine tune target-specific, ERα-mediated transcriptional activity in human breast cancer cells.

Citing Articles

A single-cell network approach to decode metabolic regulation in gynecologic and breast cancers.

Srivastava A, Vinod P NPJ Syst Biol Appl. 2025; 11(1):26.

PMID: 40082472 PMC: 11906788. DOI: 10.1038/s41540-025-00506-0.

Integration of CRISPR/dCas9-Based methylation editing with guide positioning sequencing identifies dynamic changes of mrDEGs in breast cancer progression.

Zhang B, Li J, Yu W Cell Mol Life Sci. 2025; 82(1):46.

PMID: 39833630 PMC: 11747065. DOI: 10.1007/s00018-024-05562-z.

Gene-Expression Patterns of Tumor and Peritumor Tissues of Smoking and Non-Smoking HPV-Negative Patients with Head and Neck Squamous Cell Carcinoma.

Soboleva A, Arutyunyan I, Jumaniyazova E, Vishnyakova P, Zarubina D, Nimatov E Biomedicines. 2024; 12(3).

PMID: 38540309 PMC: 10967845. DOI: 10.3390/biomedicines12030696.

PITX1 plays essential functions in cancer.

Zhao J, Xu Y Front Oncol. 2023; 13:1253238.

PMID: 37841446 PMC: 10570508. DOI: 10.3389/fonc.2023.1253238.

Stress Triggers Expression of Bovine Herpesvirus 1 Infected Cell Protein 4 (bICP4) RNA during Early Stages of Reactivation from Latency in Pharyngeal Tonsil.

Toomer G, Workman A, Harrison K, Stayton E, Hoyt P, Jones C J Virol. 2022; 96(23):e0101022.

PMID: 36416585 PMC: 9749472. DOI: 10.1128/jvi.01010-22.

References

Hall J, Couse J, Korach K . The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem. 2001; 276(40):36869-72. DOI: 10.1074/jbc.R100029200. View

Tremblay J, Marcil A, Gauthier Y, Drouin J . Ptx1 regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain. EMBO J. 1999; 18(12):3431-41. PMC: 1171422. DOI: 10.1093/emboj/18.12.3431. View

Couse J, Korach K . Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev. 1999; 20(3):358-417. DOI: 10.1210/edrv.20.3.0370. View

Laganiere J, Deblois G, Lefebvre C, Bataille A, Robert F, Giguere V . From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A. 2005; 102(33):11651-6. PMC: 1183449. DOI: 10.1073/pnas.0505575102. View

Carroll J, Meyer C, Song J, Li W, Geistlinger T, Eeckhoute J . Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006; 38(11):1289-97. DOI: 10.1038/ng1901. View

He H, Meyer C, Shin H, Bailey S, Wei G, Wang Q . Nucleosome dynamics define transcriptional enhancers. Nat Genet. 2010; 42(4):343-7. PMC: 2932437. DOI: 10.1038/ng.545. View

Richardson A, Wang Z, De Nicolo A, Lu X, Brown M, Miron A . X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell. 2006; 9(2):121-32. DOI: 10.1016/j.ccr.2006.01.013. View

Lupien M, Eeckhoute J, Meyer C, Wang Q, Zhang Y, Li W . FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell. 2008; 132(6):958-70. PMC: 2323438. DOI: 10.1016/j.cell.2008.01.018. View

Szeto D, Ryan A, OConnell S, Liu F, Kioussi C, Gleiberman A . Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev. 1999; 13(4):484-94. PMC: 316471. DOI: 10.1101/gad.13.4.484. View

10.

Welboren W, van Driel M, Janssen-Megens E, van Heeringen S, Sweep F, Span P . ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009; 28(10):1418-28. PMC: 2688537. DOI: 10.1038/emboj.2009.88. View

11.

Szeto D, Ryan A, OConnell S, Rosenfeld M . P-OTX: a PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc Natl Acad Sci U S A. 1996; 93(15):7706-10. PMC: 38811. DOI: 10.1073/pnas.93.15.7706. View

12.

Frasor J, Danes J, Komm B, Chang K, Lyttle C, Katzenellenbogen B . Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology. 2003; 144(10):4562-74. DOI: 10.1210/en.2003-0567. View

13.

McKenna N, OMalley B . Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 2002; 108(4):465-74. DOI: 10.1016/s0092-8674(02)00641-4. View

14.

Frasor J, Danes J, Funk C, Katzenellenbogen B . Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes. Proc Natl Acad Sci U S A. 2005; 102(37):13153-7. PMC: 1201577. DOI: 10.1073/pnas.0502782102. View

15.

Barnett D, Sheng S, Charn T, Waheed A, Sly W, Lin C . Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res. 2008; 68(9):3505-15. DOI: 10.1158/0008-5472.CAN-07-6151. View

16.

Katzenellenbogen B, Katzenellenbogen J . Biomedicine. Defining the "S" in SERMs. Science. 2002; 295(5564):2380-1. DOI: 10.1126/science.1070442. View

17.

Rosenfeld M, Lunyak V, Glass C . Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 2006; 20(11):1405-28. DOI: 10.1101/gad.1424806. View

18.

Luo M, Koh M, Feng J, Wu Q, Melamed P . Cross talk in hormonally regulated gene transcription through induction of estrogen receptor ubiquitylation. Mol Cell Biol. 2005; 25(16):7386-98. PMC: 1190261. DOI: 10.1128/MCB.25.16.7386-7398.2005. View

19.

Melamed P, Koh M, Preklathan P, Bei L, Hew C . Multiple mechanisms for Pitx-1 transactivation of a luteinizing hormone beta subunit gene. J Biol Chem. 2002; 277(29):26200-7. DOI: 10.1074/jbc.M201605200. View

20.

Kolfschoten I, van Leeuwen B, Berns K, Mullenders J, Beijersbergen R, Bernards R . A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell. 2005; 121(6):849-58. DOI: 10.1016/j.cell.2005.04.017. View